Protective effect of the KCNQ activator flupirtine on a model of repetitive febrile seizures

Epilepsy Research

Volumn 97, Issue 1-2, 2011, Pages 64-72

  Yu, Fang ^a   Liu, Yanlan ^a,b   Wang, Yuncui ^a,c   Yin, Jun ^a   Wang, Hui ^a   Liu, Wanhong ^a   Peng, Biwen ^a   He, Xiaohua ^a  

^a WUHAN UNIVERSITY   (China)

^b Shanghai Prison General Hospital   (China)

^c HUBEI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Flupirtine; KCNQ channel; Phenobarbital; Repetitive febrile seizures

Indexed keywords

BIOLOGICAL MARKER; FLUPIRTINE; PHENOBARBITAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DRUG EFFECT; DRUG EFFICACY; ELECTROENCEPHALOGRAM; FEBRILE CONVULSION; FEMALE; HIPPOCAMPAL CA1 REGION; LATENT PERIOD; LEARNING DISORDER; MALE; MAZE TEST; MEMORY DISORDER; NERVE CELL DEGENERATION; NEUROPROTECTION; NEWBORN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; RECURRENCE RISK; REPETITIVE FEBRILE CONVULSION; RISK REDUCTION; SEIZURE SUSCEPTIBILITY;

AMINOPYRIDINES; ANALGESICS; ANIMALS; ANTICONVULSANTS; DISEASE MODELS, ANIMAL; ELECTROENCEPHALOGRAPHY; FEMALE; FEVER; KCNQ POTASSIUM CHANNELS; MALE; MAZE LEARNING; MEMORY; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY; RECURRENCE; RISK FACTORS; SEIZURES, FEBRILE;

EID: 81055157921     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.07.005     Document Type: Article

References (40)

1. Annegers J.F., Blakley S.A., Hauser W.A., Kurland L.T. Recurrence of febrile convulsions in a population-based cohort. Epilepsy Res. 1990, 5:209-216.
2. Annegers J.F., Hauser W.A., Elveback L.R., Kurland L.T. The risk of epilepsy following febrile convulsions. Neurology 1979, 29:297-303.
3. Annegers J.F., Hauser W.A., Shirts S.B., Kurland L.T. Factors prognostic of unprovoked seizures after febrile convulsions. N. Engl. J. Med. 1987, 316:493-498.
4. Baram T.Z., Shinnar S. Febrile Seizures 2001, vol. 18. Academic Press, pp. 9-201. 1st ed.
5. Berg A.T., Shinnar S. Unprovoked seizures in children with febrile seizures: short-term outcome. Neurology 1996, 47:562-568.
6. Boscia F., Annunziato L., Taglialatela M. Retigabine and flupirtine exert neuroprotective actions in organotypic hippocampal cultures. Neuropharmacology 2006, 51:283-294.
7. Brown D.A., Passmore G.M. Neural KCNQ (Kv7) channels. Br. J. Pharmacol. 2009, 156:1185-1195.
8. Castaldo P., del Giudice E.M., Coppola G., Pascotto A., Annunziato L., Taglialatela M. Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels. J. Neurosci. 2002, 22:RC199.
9. Chang Y.C., Huang A.M., Kuo Y.M., Wang S.T., Chang Y.Y., Huang C.C. Febrile seizures impair memory and cAMP response-element binding protein activation. Ann. Neurol. 2003, 54:706-718.
10. Chang Y.C., Kuo Y.M., Huang A.M., Huang C.C. Repetitive febrile seizures in rat pups cause long-lasting deficits in synaptic plasticity and NR2A tyrosine phosphorylation. Neurobiol. Dis. 2005, 18:466-475.
11. Chen J., Qin J., Liu X.Y., Han Y., Yang Z.X., Chang X.Z., Ji X.N. Nitric oxide-mediated neuronal apoptosis in rats with recurrent febrile seizures through endoplasmic reticulum stress pathway. Neurosci. Lett. 2008, 443:134-139.
12. Cooper E.C., Jan L.Y. M-channels: neurological diseases, neuromodulation, and drug development. Arch. Neurol. 2003, 60:496-500.
13. Dobbing J., Sands J. Quantitative growth and development of human brain. Arch. Dis. Child. 1973, 48:757-767.
14. Dube C.M., Zhou J.L., Hamamura M., Zhao Q., Ring A., Abrahams J., McIntyre K., Nalcioglu O., Shatskih T., Baram T.Z., Holmes G.L. Cognitive dysfunction after experimental febrile seizures. Exp. Neurol. 2009, 215:167-177.
15. Gottlieb A., Keydar I., Epstein H.T. Rodent brain growth stages: an analytical review. Biol. Neonate 1977, 32:166-176.
16. Hauser W.A. The prevalence and incidence of convulsive disorders in children. Epilepsia 1994, 35(Suppl. 2):S1-S6.
17. Jensen F.E., Baram T.Z. Developmental seizures induced by common early-life insults: short- and long-term effects on seizure susceptibility. Ment. Retard. Dev. Disabil. Res. Rev. 2000, 6:253-257.
18. Jentsch T.J. Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev. Neurosci. 2000, 1:21-30.
19. Klawe C., Maschke M. Flupirtine: pharmacology and clinical applications of a nonopioid analgesic and potentially neuroprotective compound. Expert Opin. Pharmacother. 2009, 10:1495-1500.
20. Lux A.L. Antipyretic drugs do not reduce recurrences of febrile seizures in children with previous febrile seizure. Evid. Based Med. 2010, 15:15-16.
21. Lux A.L. Treatment of febrile seizures: historical perspective, current opinions, and potential future directions. Brain Dev. 2010, 32:42-50.
22. Miceli F., Soldovieri M.V., Martire M., Taglialatela M. Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr. Opin. Pharmacol. 2008, 8:65-74.
23. Offringa M., Bossuyt P.M., Lubsen J., Ellenberg J.H., Nelson K.B., Knudsen F.U., Annegers J.F., el-Radhi A.S., Habbema J.D., Derksen-Lubsen G., et al. Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies. J. Pediatr. 1994, 124:574-584.
24. Okada M., Zhu G., Hirose S., Ito K.I., Murakami T., Wakui M., Kaneko S. Age-dependent modulation of hippocampal excitability by KCNQ-channels. Epilepsy Res. 2003, 53:81-94.
25. Otto M., Cepek L., Ratzka P., Doehlinger S., Boekhoff I., Wiltfang J., Irle E., Pergande G., Ellers-Lenz B., Windl O., Kretzschmar H.A., Poser S., Prange H. Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study. Neurology 2004, 62:714-718.
26. Palmer G.C., Borrelli A.R., Hudzik T.J., Sparber S. Acute heat stress model of seizures in weanling rats: influence of prototypic anti-seizure compounds. Epilepsy Res. 1998, 30:203-217.
27. Peters H.C., Hu H., Pongs O., Storm J.F., Isbrandt D. Conditional transgenic suppression of M channels in mouse brain reveals functions in neuronal excitability, resonance and behavior. Nat. Neurosci. 2005, 8:51-60.
28. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 1972, 32:281-294.
29. Raol Y.H., Lapides D.A., Keating J.G., Brooks-Kayal A.R., Cooper E.C. A KCNQ channel opener for experimental neonatal seizures and status epilepticus. Ann. Neurol. 2009, 65:326-336.
30. Safiulina V.F., Zacchi P., Taglialatela M., Yaari Y., Cherubini E. Low expression of Kv7/M channels facilitates intrinsic and network bursting in the developing rat hippocampus. J. Physiol. 2008, 586:5437-5453.
31. Sattler M.B., Williams S.K., Neusch C., Otto M., Pehlke J.R., Bahr M., Diem R. Flupirtine as neuroprotective add-on therapy in autoimmune optic neuritis. Am. J. Pathol. 2008, 173:1496-1507.
32. Singh N.A., Westenskow P., Charlier C., Pappas C., Leslie J., Dillon J., Anderson V.E., Sanguinetti M.C., Leppert M.F. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum. Brain 2003, 126:2726-2737.
33. Strengell T., Uhari M., Tarkka R., Uusimaa J., Alen R., Lautala P., Rantala H. Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. Arch. Pediatr. Adolesc. Med. 2009, 163:799-804.
34. Tosun A., Koturoglu G., Serdaroglu G., Polat M., Kurugol Z., Gokben S., Tekgul H. Ratios of nine risk factors in children with recurrent febrile seizures. Pediatr. Neurol. 2010, 43:177-182.
35. Toth Z., Yan X.X., Haftoglou S., Ribak C.E., Baram T.Z. Seizure-induced neuronal injury: vulnerability to febrile seizures in an immature rat model. J. Neurosci. 1998, 18:4285-4294.
36. Van Esch A., Van Steensel-Moll H.A., Steyerberg E.W., Offringa M., Habbema J.D., Derksen-Lubsen G. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch. Pediatr. Adolesc. Med. 1995, 149:632-637.
37. Wang H.S., Pan Z., Shi W., Brown B.S., Wymore R.S., Cohen I.S., Dixon J.E., McKinnon D. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 1998, 282:1890-1893.
38. Weber Y.G., Geiger J., Kampchen K., Landwehrmeyer B., Sommer C., Lerche H. Immunohistochemical analysis of KCNQ2 potassium channels in adult and developing mouse brain. Brain Res. 2006, 1077:1-6.
39. Wolf S.M., Forsythe A. Epilepsy and mental retardation following febrile seizures in childhood. Acta Paediatr. Scand. 1989, 78:291-295.
40. Yang L., Li F., Zhang H., Ge W., Mi C., Sun R., Liu C. Astrocyte activation and memory impairment in the repetitive febrile seizures model. Epilepsy Res. 2009, 86:209-220.